Granulocyte-macrophage colony-stimulating factor alone or with dacarbazine in metastatic melanoma: a randomized phase II trial

The potential antitumoural effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) led us to evaluate GM-CSF alone or with dacarbazine (DTIC) in metastatic melanoma in first line randomized phase II. Treatment was arm A: GM-CSF: 5 μg kg(−1), bid, 14 consecutive days every 21 days and arm...

Descripción completa

Detalles Bibliográficos
Autores principales: Ravaud, A, Delaunay, M, Chevreau, C, Coulon, V, Debled, M, Bret-Dibat, C, Courbon, F, Gualde, N, Bui, B Nguyen
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363949/
https://www.ncbi.nlm.nih.gov/pubmed/11720430
http://dx.doi.org/10.1054/bjoc.2001.2120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363949/
https://www.ncbi.nlm.nih.gov/pubmed/11720430
http://dx.doi.org/10.1054/bjoc.2001.2120

Ejemplares similares